Cytokinetics Inc Income Statement

Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 127.73M2.58M4.00M7.56M30.65M46.94M28.66M106.41M13.37M31.50M26.87M36.50M54.90M94.59M7.53M15.00M
Gross Profit 127.73M2.58M4.00M7.56M30.65M46.94M28.66M106.41M13.37M31.50M26.87M36.50M54.90M94.59M7.53M15.00M
Operating items
Research & Development 62.41M58.75M37.18M35.64M49.45M44.43M46.40M59.90M90.30M89.14M86.12M96.95M159.94M240.81M330.12M339.41M
Selling, General & Administrative 24.48M14.20M13.59M12.43M15.09M17.27M19.67M27.82M36.47M31.28M39.61M52.82M96.80M177.98M173.61M215.31M
Restructuring Costs -0.04M3.79M1.19M-0.06M
Other Operating Expenses -24.53M
Operating Expenses 86.85M52.21M51.96M48.02M64.54M61.69M66.06M87.72M126.76M120.42M125.73M149.77M256.74M418.79M503.74M554.72M
Operating Income 103.17M-49.63M-47.96M-40.46M-33.89M-14.75M-37.41M18.69M-113.40M-88.92M-98.87M-93.94M-186.31M-324.20M-496.20M-536.25M
EBIT 103.17M-49.63M-47.96M-40.46M-33.89M-14.75M-37.41M18.69M-113.40M-88.92M-98.87M-93.94M-186.31M-324.20M-496.20M-536.25M
Non-operating items
Interest & Investment Income -2.60M28.87M0.14M0.09M0.18M0.11M0.16M
Other Non Operating Income -19.60M
Non Operating Income -2.19M0.17M0.10M0.09M0.18M0.11M0.17M0.46M2.60M4.19M4.54M5.33M0.33M11.34M27.63M51.53M
Net income details
EBT 24.69M-49.46M-47.86M-40.37M-33.72M-14.65M-37.50M16.45M-116.41M-92.71M-105.49M-109.91M-202.75M-343.62M-524.51M-573.95M
Tax Provisions 0.23M-0.27M
Profit After Tax 38.45M-49.29M-47.86M-40.37M-33.72M-14.65M-37.50M16.45M-127.79M-106.29M-121.69M-127.29M-215.31M-388.95M-526.24M-589.53M
Income from Continuing Operations 24.46M-49.19M-47.86M-40.37M-33.72M-14.65M-37.50M16.45M-116.41M-92.71M-105.49M-109.91M-202.75M-343.62M-524.51M-573.95M
Consolidated Net Income 24.46M-49.19M-47.86M-40.37M-33.72M-14.65M-37.50M16.45M-116.41M-92.71M-105.49M-109.91M-202.75M-343.62M-524.51M-573.95M
Income towards Parent Company 24.46M-49.19M-47.86M-40.37M-33.72M-14.65M-37.50M16.45M-116.41M-92.71M-105.49M-109.91M-202.75M-343.62M-524.51M-573.95M
Preferred Dividend Payments 2.86M1.31M
Net Income towards Common Stockholders 24.54M-49.29M-50.72M-41.68M-33.72M-14.65M-37.50M16.45M-116.41M-92.71M-105.49M-109.91M-202.75M-343.62M-524.51M-573.95M
Additional items
EPS (Basic) 0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) 0.00M-0.00M-0.00M-0.00M-0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 10.15M10.98M12.05M23.74M29.50M36.61M38.85M40.52M53.88M54.71M59.08M70.78M83.88M94.63M98.05M118.01M
Shares Outstanding (Diluted Average) 0.09M0.10M70.80M0.06M0.08M0.09M0.10M0.11M
EBITDA 103.17M-49.63M-47.85M-40.35M-33.73M-14.66M-37.35M16.44M-127.58M-106.13M-121.51M-127.82M-216.33M-391.68M-522.66M-587.12M
Tax Rate 0.95%0.55%